Yes, based on its effects. But it doesn’t work via the serotonin 5-HT2A receptor like other psychedelics.
Scientists Synthesize and Test the Magic Mushroom Compounds Baeocystin, Norbaeocystin, Norpsilocin, and Aeruginascin
This work is a giant step forward for psychedelic research.
The Miller School of Medicine is Studying CBD + Psilocybin for Treating Traumatic Brain Injury and PTSD
The University of Miami medical school study is funded by a $1.624 million grant from Tassili Life Sciences.
Recent evidence suggests psychedelics may significantly improve addiction treatment outcomes.
Recent research suggests that psilocybin causes changes in amygdala activity opposite to those seen in conventional antidepressant treatment.
Activation of neuronal 5-HT1A receptors causes hyperpolarization and inhibition of cellular signaling.
Decriminalize Nature DC is driving the effort to get the initiative on the November ballot.
Even slightly modifying the chemical structure of the compounds in kratom can significantly alter their effects.
UK Health Technology Assessment body raises questions over the clinical and cost-effectiveness of Spravato (esketamine).
Technically the answer is no, but subjective experiences may vary.